Your browser doesn't support javascript.
loading
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts.
Ungaro, Ryan C; Limketkai, Berkeley N; Jensen, Camilla Bjørn; Allin, Kristine Højgaard; Agrawal, Manasi; Ullman, Thomas; Colombel, Jean-Frederic; Jess, Tine.
Afiliación
  • Ungaro RC; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Limketkai BN; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
  • Jensen CB; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.
  • Allin KH; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.
  • Agrawal M; Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Ullman T; Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Jess T; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.
Gut ; 68(6): 977-984, 2019 06.
Article en En | MEDLINE | ID: mdl-30420398

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Biológica / Colitis Ulcerosa / Antiinflamatorios no Esteroideos / Mesalamina Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Europa Idioma: En Revista: Gut Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Biológica / Colitis Ulcerosa / Antiinflamatorios no Esteroideos / Mesalamina Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Europa Idioma: En Revista: Gut Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos